CardioMed Device Consultants are leading the Artificial Intelligence & Digital Health Session (March 9, 2026; 8:00 AM – 12:30 PM ET) at CRT 2026, bringing together leading clinicians, researchers, and innovators to explore the evolving role of artificial intelligence in cardiovascular medicine.
The session will highlight key advancements in AI-driven coronary and endovascular interventions, clinical decision-making and procedure planning, and the growing role of wearables, digital health technologies, and real-world data. Additional discussions will focus on emerging applications of predictive modeling, generative AI, and large language models, as well as regulatory considerations, including FDA perspectives on AI/ML-enabled medical technologies.
CardioMed will also participate in sessions discussing how to move from EFS to pivotal clinical studies and Tricuspid valve investigational studies.
CardioMed